Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

Chief Medical Officer Schoenberg Mark sold $350,100 worth of Ordinary Shares (10,000 units at $35.01) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 129,763 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
URGN· UroGen Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.